mebendazole has been researched along with paclitaxel in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abou El-Magd, RM; Arakawa, K; Ayoub, AT; Chan, G; Glover, M; Klobukowski, M; Lewis, CW; Nindita, Y; Sun, L; Tilli, TM; Tuszynski, J; Xiao, J | 1 |
| Cheong, JE; Chung, I; Jernigan, FE; Sun, L; Wang, Y; Xu, Y; Zaffagni, M; Zetter, BR | 1 |
| Cappuccinelli, P; Juliano, C; Monaco, G; Rubino, S | 1 |
| Bandiera, P; Cappuccinelli, P; Juliano, C; Monaco, G; Tedde, G | 1 |
| Chada, S; Gomyo, Y; Mukhopadhyay, T; Ramesh, R; Roth, JA; Sasaki, J | 1 |
| Čáňová, K; Hanušová, V; Knoppová, K; Králová, V; Skálová, L; Staňková, P | 1 |
| Abdolahad, M; Amiri, MH; Gharooni, M; Khosravi, S; Namdar, N; Zanganeh, S | 1 |
1 review(s) available for mebendazole and paclitaxel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for mebendazole and paclitaxel
| Article | Year |
|---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antitumor Activity of Lankacidin Group Antibiotics Is Due to Microtubule Stabilization via a Paclitaxel-like Mechanism.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Binding Sites; Brain; Cell Survival; Dose-Response Relationship, Drug; HeLa Cells; Humans; Macrolides; Microtubules; Molecular Conformation; Molecular Dynamics Simulation; Paclitaxel; Structure-Activity Relationship; Swine; Tubulin; Tumor Cells, Cultured | 2016 |
Synthesis and anticancer activity of novel water soluble benzimidazole carbamates.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Carbamates; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Male; Mice; Molecular Docking Simulation; Molecular Structure; Neoplasms, Experimental; Solubility; Structure-Activity Relationship; Tumor Cells, Cultured; Water | 2018 |
Inhibition of Trichomonas vaginalis replication by the microtubule stabilizer taxol.
Topics: Alkaloids; Animals; Cytoskeleton; Fluorescent Antibody Technique; Mebendazole; Microscopy, Electron, Scanning; Microtubules; Mitotic Index; Paclitaxel; Trichomonas vaginalis | 1986 |
Action of anticytoskeletal compounds on in vitro cytopathic effect, phagocytosis, and adhesiveness of Trichomonas vaginalis.
Topics: Alkaloids; Animals; Bacterial Adhesion; Cells, Cultured; Colchicine; Cytochalasin B; Cytoskeleton; Fibroblasts; Griseofulvin; Mebendazole; Mice; Mice, Inbred Strains; Paclitaxel; Phagocytosis; Trichomonas vaginalis | 1987 |
The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells.
Topics: Administration, Oral; Animals; Antinematodal Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Cycle; Cytochrome c Group; Flow Cytometry; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Mebendazole; Mice; Mice, Nude; Microscopy, Fluorescence; Mitochondria; Paclitaxel; Spindle Apparatus; Tubulin; Tumor Cells, Cultured | 2002 |
Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines.
Topics: Adenocarcinoma; Albendazole; Anthelmintics; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; G2 Phase; Humans; Inhibitory Concentration 50; Intestinal Neoplasms; Mebendazole; Microtubules; Paclitaxel; Protein Stability; Tubulin Modulators | 2013 |
Electrochemical approach for monitoring the effect of anti tubulin drugs on breast cancer cells based on silicon nanograss electrodes.
Topics: Breast Neoplasms; Electrodes; Female; Humans; MCF-7 Cells; Mebendazole; Nanotechnology; Paclitaxel; Silicon; Tubulin | 2016 |